Daily Dispatch

The 'Dispatched' Podcast

News EN ↓ 209 episodes

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

Be sure to visit the podcast's website and support the creator: bpd.captivate.fm

Author

Daily Dispatch

Category

News

Podcast website

bpd.captivate.fm

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Amgen's Ian Noble - 'If it doesn't get measured, it doesn't get done' 13.12.2021

Amgen's director of value, access and policy, Ian Noble, says Australia needs a clear vision to address the 820-day medicines 'access gap'.He says Amgen was disappointed with the report of the recent parliamentary inquiry and that a vision and agreed principles are essential to ensuring the pending health technology assessment review avoids becoming just another negotiation and actu...

How the National Medicines Policy review is just exposing the problem 11.12.2021

We discuss the claim Australia's most important document for medicines policy does not require a vision or overarching objective and why the National Medicines Policy review so far says everything people need to know about the problems afflicting PBS decision-making.

Dr Brendan Shaw - Australians now understand there is a 'queue' for new health technologies 06.12.2021

Dr Brendan Shaw of Shawview Consulting discusses the findings of his report commissioned by Johnson & Johnson on 'Getting Australia to the front of the queue' when it comes to access to new medicines and medical technologies. Dr Shaw says a key lesson of the COVID-19 pandemic has been the reality of a global queue for new technologies, including vaccines. He says the experience means...

‘The things you can learn in 15 minutes - the power of parliamentary scrutiny’ 01.12.2021

The Senate backed the enabling legislation for the new PBS pricing framework but only after questioning from a key crossbencher that revealed more about the secret list of medicines used to calculate the $1.9 billion in savings. We also discuss the expected announcement of Greg Hunt's retirement and what about his successor will provide a very important signal on the government's plan fo...

MA's Liz de Somer responds to the parliamentary inquiry report and looks ahead to 2022 29.11.2021

The chief executive of Medicines Australia, Liz de Somer, discussed the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies, how the recommendations relate to the association's new agreement with the federal government and looks ahead to what will be a very busy 2022.

BeiGene's Adam Roach - 'Looking to change the conversation' 28.11.2021

BeiGene's vice president of commercial for the Asia Pacific region Adam Roach discusses his background, career to date, disruption, as well as the company's plans for Australia and the region. He also shares his thoughts on some of the issues impacting medicines reimbursement, decision-making and patients.

The 'Zimmerman' inquiry - the good, the not so good and what now? 24.11.2021

BioPharmaDispatch discusses the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies with Better Access Australia co-founder and chair Felicity McNeill. We discuss the recommendations, the lack of any overarching objective and what the raft of proposed processes and reviews actually mean.

Rare Cancers' Richard Vines - 'Time to get real about patient centricity' 23.11.2021

The co-founder and CEO of Rare Cancers Australia speaks with BioPharmaDispatch ahead of the organisation's CanForum event. He discusses its new report on the 'rights and responsibilities' of patients in Australia's health system and how to give real meaning to the notion of 'patient centricity'.

Nicole Cooper - 'We have to do better than this' 19.11.2021

Nicole Cooper is the managing director of change management company Convalis Consulting. She is also a patient living with advanced colorectal cancer. She discusses her experiences of the health system, submission to the National Medicines Policy review and the urgent need for connection between decision-making and the lived experience of patients.

Listen to the The 'Dispatched' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.